HighTower Advisors
IMVT icon

HighTower Advisors’s Immunovant IMVT Stock Holding History

HighTower Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16M Sell
56,104
-640
-1% -$19.5K ﹤0.01% 1716
2026
Q1 		$1.41M Buy
56,744
+23,336
+70% +$604K ﹤0.01% 1950
2025
Q4 		$849K Hold
33,408
– – ﹤0.01% 2242
2025
Q3 		$539K Buy
33,408
+16
+0% +$259 ﹤0.01% 2559
2025
Q2 		$534K Buy
33,392
+119
+0.4% +$1.8K ﹤0.01% 2464
2025
Q1 		$569K Buy
33,273
+238
+0.7% +$4.98K ﹤0.01% 2351
2024
Q4 		$818K Sell
33,035
-189
-0.6% -$5.36K ﹤0.01% 2114
2024
Q3 		$947K Buy
33,224
+7,259
+28% +$214K ﹤0.01% 1957
2024
Q2 		$685K Sell
25,965
-1,379
-5% -$39.2K ﹤0.01% 2097
2024
Q1 		$884K Buy
27,344
+21
+0.1% +$766 ﹤0.01% 1879
2023
Q4 		$1.15M Buy
27,323
+3,000
+12% +$110K ﹤0.01% 1773
2023
Q3 		$933K Buy
24,323
+76
+0.3% +$1.72K ﹤0.01% 1816
2023
Q2 		$460K Hold
24,247
– – ﹤0.01% 2260
2023
Q1 		$376K Hold
24,247
– – ﹤0.01% 2296
2022
Q4 		$431K Hold
24,247
– – ﹤0.01% 2226
2022
Q3 		$135K Hold
24,247
– – ﹤0.01% 2704
2022
Q2 		$94K Hold
24,247
– – ﹤0.01% 2799
2022
Q1 		$134K Hold
24,247
– – ﹤0.01% 2928
2021
Q4 		$206K Buy
+24,247
New +$200K ﹤0.01% 2754
2021
Q1 		– Sell
-4,600
Closed -$209K – 3153
2020
Q4 		$209K Buy
+4,600
New +$213K ﹤0.01% 2174

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

HighTower Advisors's IMVT Position: Q2 2026 in Review

HighTower Advisors reduced its Immunovant (IMVT) stake by 1.1% in Q2 2026, selling an estimated $19.5K and leaving 56,104 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

HighTower Advisors first reported a position in IMVT in Q4 2020 and has held it in 20 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • HighTower Advisors held 56,104 shares of Immunovant worth $2.16M as of Q2 2026.
  • HighTower Advisors sold 640 Immunovant shares in Q2 2026, an estimated $19.5K.
  • Immunovant made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1716 holding.
  • HighTower Advisors first reported a position in Immunovant in Q4 2020 and has held it in 20 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.